Target Validation in Drug Discovery

Collectif

Ouvrage indisponible

Éditeur
Academic Press Inc
Pages
296
Parution
novembre 2006
Format
Cartonné
Langue
Anglais
Dimensions
260 × 184 × 24 cm
EAN
9780123693938
  • Résumé

Presents a comprehensive framework for approaching target validation in drug discovery. This work begins with a description of enabling technologies, including aptamers, RNA interference, and proteomics. It, then, looks at biologic drug development with discussion of lessons learned from such well-known cases as Erbitux, Herceptin, and Avastin.
Bio de l'auteur
Sommaire / contenu
Nous vous suggérons aussi
Retour en haut de page